Anticancer Potential of Hydroxychavicol Derived from Piper betle L: An in Silico and Cytotoxicity Study

References

• Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;29:270–278.
   Web of Science ®Google Scholar
• Ozcan T, Delikanli B. Phenolics in human health. Int J Chem Eng Appl. 2016;5:393–396. doi:10.7763/IJCEA.2014.V5.416
   Google Scholar
• Das S, Parida R, Sandeep IS, Nayak S, and Mohanty S. Biotechnological intervention in betelvine (Piper betle L.): a review on recent advances and future prospects. Asian Pac J Trop Med. 2016;9:938–946. doi:10.1016/j.apjtm.2016.07.029
   PubMed Web of Science ®Google Scholar
• Nagabhushan M, Amonkar AJ, Nair UJ, D’Souza AV, Bhide SV. Hydroxychavicol a new anti-nitrosating phenolic compound from betel leaf. Mutagenesis 1989;4:200–204. doi:10.1093/mutage/4.3.200
   PubMed Web of Science ®Google Scholar
• Rahman AA, Jamal ARA, Harun R, Mokhtar NM, Ngah WZW. Gamma-tocotrienol and hydroxychavicol synergistically inhibits growth and induces apoptosis of human gliomacells. BMC Complem Altern Med. 2014;14:213–234. doi:10.1186/1472-6882-14-213
   PubMed Web of Science ®Google Scholar
• Jeng JH, Wang YJ, Chang WH, Wu HL, Li CH. Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells. Cell Mol Life Sci (abstr). 2004;61:83–96. doi:10.1007/s00018-003-3272-8
   PubMed Web of Science ®Google Scholar
• Chakraborty JB, Mahato SK, Joshi K, Shinde V, Rakshit S, et al. Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. Cancer Sci. 2012;103:88–99. doi:10.1111/j.1349-7006.2011.02107.x
   PubMed Web of Science ®Google Scholar
• Hagerstrand D, Tong A, Schumacher SE, Ilic N, Shen RR, et al. Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers. Cancer Discov. 2013;3:1044–1057. doi:10.1158/2159-8290.CD-12-0592
   PubMed Web of Science ®Google Scholar
• Bundela S, Sharma A, and Bisen PS. Potential therapeutic targets for oral cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70. PLoS One 2014; 9: e102610. doi:10.1371/journal.pone.0102610
   PubMed Web of Science ®Google Scholar
• Song M, Bode AM, Dong Z, Zigang Z, and Lee M. AKT as a therapeutic target for cancer. Cancer Res. 2019;73:1019–1031. doi:10.1158/0008-5472.CAN-18-2738
   Web of Science ®Google Scholar
• Sigismund S,Avanzato D, and Lanzetti L. Emerging functions of the EGFR in cancer. Moloncol 2018;12:3–20. doi:10.1002/1878-0261.12155
   Google Scholar
• Bhatia S, Griego A, Lennon S, Oweida A, Sharma J, et al. Role of EphB3 receptor in mediating head and neck tumor growth, cell migration, and response to PI3K inhibitor. Mol Cancer Ther. 2018;17:2049–2059. doi:10.1158/1535-7163.MCT-17-1163
   PubMed Web of Science ®Google Scholar
• Ji X, Li G, Feng Y, Zhao J, Li J, et al. EphB3 Is overexpressed in non–small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration. Cancer Res. 2011;71:1156–1166. doi:10.1158/0008-5472.CAN-10-0717
   PubMed Web of Science ®Google Scholar
• Vescarelli E, Ceccarelli S, and Angeloni A. Role of fibroblast growth factor receptor 2 in pancreatic cancer: potential target for new therapeutic approach? Pancreat Disord Ther. 2015;5:3–7.
   Google Scholar
• Shattuck DL, Miller JK, Carraway KL, Sweeney C. Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells. Cancer Res. 2008;68:1471–1477. doi:10.1158/0008-5472.CAN-07-5962
   PubMed Web of Science ®Google Scholar
• Ingley E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Sign. 2012;10:21–32. doi:10.1186/1478-811X-10-21
   PubMed Web of Science ®Google Scholar
• Bleeker FE, Lamba S, Zanon C, Molenaar RJ, Hulsebos TJ, et al. Mutational profiling of kinases in glioblastoma. BMC Cancer 2014;14:718–730. doi:10.1186/1471-2407-14-718
   PubMed Web of Science ®Google Scholar
• Lian L, Li X, Xu M, Li X, Wu M, et al. VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer. BMC Cancer 2019;19:183–198. doi:10.1186/s12885-019-5322-0
   PubMed Web of Science ®Google Scholar
• Milella M, Falcone I, Conciatori F, Incani UC, Curatolo AD, et al. PTEN: Multiple functions in human malignant tumors. Front Oncol. 2015;5:24–38.
   PubMed Web of Science ®Google Scholar
• Rowshanravan B, Halliday N, and Sansom DM. CTLA-4: a moving target in immunotherapy. Blood 2018;131:58–67. doi:10.1182/blood-2017-06-741033
   PubMed Web of Science ®Google Scholar
• Yakoub S, El-Chami N, Kaszas K, Sirkasi M, Smith CA et al. The proto-oncoprotein c-Cbl protects cells against oxidative stress by down regulating apoptosis and is highly expressed in several cancers. J Cancer Sci Ther 2014; 6: 122–135.
   Google Scholar
• Lamora A, Talbot J, Mullard M, Royer BB, Redini F et al. TGF-β Signaling in bone remodeling and osteosarcoma progression. J Clin Med 2016;5:96–107. doi:10.3390/jcm5110096
   PubMed Web of Science ®Google Scholar
• Pei Y, Li G, Ran J, Wei. Kinesin family member 11 contributes to the progression and prognosis of human breast cancer. Oncol Lett 2017;14:6618–6626. doi:10.3892/ol.2017.7053
   PubMed Web of Science ®Google Scholar
• Roth AD, Tejpar S, Delorenzi M, Yan P, Fiocca R, et al. Prognostic role of KRAS and BRAF in Stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60–00 Trial. J Clin Oncol. 2010;28:466–474.
   PubMed Web of Science ®Google Scholar
• Kwong LN, and Dove WF. APC and its modifiers in colon cancer. Adv Exp Med Biol. 2009;656:85–106. doi:10.1007/978-1-4419-1145-2_8
   PubMed Web of Science ®Google Scholar
• Morris GM, Goodsell S, Halliday RS, Huey R, Hart WE et al. Automated docking using Lamarckian algorithm and an empirical binding free energy function. J Comput Chem. 1998;19:1639–1662. doi:10.1002/(SICI)1096-987X(19981115)19:14<1639:AID-JCC10>3.0.CO;2-B
   Web of Science ®Google Scholar
• Binkowski TA, Naghibzadeh S, and Liang J. CAST p: Computed atlas of surface topography of proteins. Nucleic Acids Res 2003;31:3352–3355. doi:10.1093/nar/gkg512
   PubMed Web of Science ®Google Scholar
• Hetenyi C, and Spoel DVD. Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci. 2002;11:1729–1737.
   PubMed Web of Science ®Google Scholar
• Caroli A, Ballante F, Wickersham RB, Corelli F, and Ragno R. Hsp90 inhibitors, Part 2: combining ligand-based and structurebased approaches for virtual screening application. J Chem Inf Model 2014;54:970−977. doi:10.1021/ci400760a
   PubMed Web of Science ®Google Scholar
• Lawrie TA, Rabbie R, Thoma C and Morisson J. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer. Cochrane Database Syst Rev, 2013(10):CD010482.
   PubMed Web of Science ®Google Scholar
• Samadder NJ, Neklason DW, Boucher KM, Byrne KR, Kanth P, et al. Effect of sulindac and erlotinibvs placebo on duodenal neoplasia in familial adenomatous polyposis: a randomized clinical trial. JAMA 2016;315(12):1266–1275. doi:10.1001/jama.2016.2522
   PubMed Web of Science ®Google Scholar
• Wang A, Li Y, Zhao Q and Fani L. Formononetin inhibits colon carcinoma cell growth and invasion by microRNA-149-mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways. Mol Med Rep 2018;17:7721–7729.
   PubMed Web of Science ®Google Scholar
• Robert C, Thomas L, Bondarenko I, Day S, Weber, et al.: Ipilimumab plus Dacarbazine for previously untreated metastatic melanoma. N Engl J Med 2011;364:26–36. doi:10.1056/NEJMoa1104621
   Web of Science ®Google Scholar
• Gong J, Chen Y, Yang L, Pillai R, Shirasawa S, et al. MEK162 enhances antitumor activity of-fluorouracil and trifluridine in KRAS-mutated human colorectal cancer cell lines. Anti-cancer Res. 2017;37:2831–2838.
   PubMed Web of Science ®Google Scholar
• Silva JK, Trindade R, Alves NS, Figueiredo PL, Maia JGS, et al. Essential oils from neotropical Piper species and their biological activities. Int J Mol Sci 2014;18:2571–2613. doi:10.3390/ijms18122571
   Web of Science ®Google Scholar
• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev 2004; 3: 711–715. doi:10.1038/nrd1470
   Google Scholar
• Ritchie TJ, Ertl P, and Lewis R. The graphical representation of ADME-related molecule properties for medicinal chemists. Drug Discov Today 2011;16;65–72. doi:10.1016/j.drudis.2010.11.002
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, and Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Cheng F, Li W, Zhou Y, Shen J, Wu Z et al. AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model 2012;52:099–3105. doi:10.1021/ci300367a
   PubMed Web of Science ®Google Scholar
• Amin ML. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 2013; 7; 27–34. doi:10.4137/DTI.S12519
   PubMedGoogle Scholar
• McDonnell AM, Dang CH. Basic Review of the Cytochrome P450 System. J Adv Pract Oncol 2013;4:263–268.
   PubMedGoogle Scholar
• Potts RO, and Guy RH. Predicting skin permeability. Pharm Res(abstr) 1992;9:663–669. doi:10.1023/A:1015810312465
   Web of Science ®Google Scholar
• Borodina YV, Filimonov DA and Poroikov VV. Computer-aided prediction of prodrug activity using the pass system. Pharm Chem J. 1996;30:760–763. doi:10.1007/BF02218831
   Google Scholar
• Paranjpe R, Gundala SR, Lakshminarayana N, Sagwal A, Asif G et al. Piper betle leaf extract: anti-cancer benefits and bio-guided fractionation to identify active principles for prostate cancer management. Carcinogenesis 2013;34:1558–1566. doi:10.1093/carcin/bgt066
   PubMed Web of Science ®Google Scholar
• MajumdarAG, Subramanian M. Hydroxychavicol from Piper betle induces apoptosis, cell cycle arrest and inhibits epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Pharmacol 2019;166:274–291. doi:10.1016/j.bcp.2019.05.025
   PubMed Web of Science ®Google Scholar
• Lopez JR, Limon AV, Zunaiga MA, Jimanez VA, Alderete JB, et al. Molecular modeling simulation studies reveal new potential inhibitors against HPV E6 protein. PLoS One 2019;14:e0213028. doi:10.1371/journal.pone.0213028
   PubMed Web of Science ®Google Scholar
• Gundala SR, Yang C, Mukkavilli R, Paranjpe R, Brahmbhatt M, et al. Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis. Toxicol Appl Pharm 2014; 280: 86–96. doi:10.1016/j.taap.2014.07.012
   PubMed Web of Science ®Google Scholar
• Cicenas J, Zalyte E, Bairoch A, Gaudet P. Kinases and Cancer. Cancers 2018;10:63–70. doi:10.3390/cancers10030063
   PubMed Web of Science ®Google Scholar
• Penuelas S, Anido J, Prieto-Sánchez RM, Folch G, Barba I et al. TGF-β increases glioma initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009;15:315–327. doi:10.1016/j.ccr.2009.02.011
   PubMed Web of Science ®Google Scholar
• Papageorgis P. TGFβ signaling in tumor initiation, epithelial-tomesenchymal transition, and metastasis. J Oncol 2015; 587193. doi:10.1155/2015/587193
   PubMed Web of Science ®Google Scholar
• Colak S, Dijke PT. Targeting TGF-β signaling in cancer. Trends Cancer 2017;3:56–71. doi:10.1016/j.trecan.2016.11.008
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, Haldar S, Sun H, Koeppe RE, Chattopadhyay A. Importance of indole N-H hydrogen bonding in the organization and dynamics of gramicidin channels. Biochem Biophys Acta 2014;1838:419–428. doi:10.1016/j.bbamem.2013.10.011
   PubMed Web of Science ®Google Scholar
• Huynh H, Lee LY, Goh KY, Ong R, Hao H, et al. Infigratinib mediates vascular normalization, impairs metastasis and improves chemotherapy in hepatocellular carcinoma. Hepatology. 2019;69(3):943–958. doi:10.1002/hep.30481
   PubMed Web of Science ®Google Scholar
• Rajedadram A, Pin KY, Ling SK, Yan SW, Looi ML. Hydroxychavicol, a polyphenol from Piper betle leaf extract, induces cell cycle arrest and apoptosis in TP53-resistant HT-29 colon cancer cells. J Zhejiang Univ Sci B. 2021;22(2):112–122. doi:10.1631/jzus.B2000446
   PubMed Web of Science ®Google Scholar